Back to Search
Start Over
Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm
- Source :
- Scientific Reports, Repisalud, Instituto de Salud Carlos III (ISCIII)
- Publication Year :
- 2016
- Publisher :
- Nature Publishing Group, 2016.
-
Abstract
- High-density lipoproteins (HDLs) are complex protein and lipid assemblies whose composition is known to change in diverse pathological situations. Analysis of the HDL proteome can thus provide insight into the main mechanisms underlying abdominal aortic aneurysm (AAA) and potentially detect novel systemic biomarkers. We performed a multiplexed quantitative proteomics analysis of HDLs isolated from plasma of AAA patients (N = 14) and control study participants (N = 7). Validation was performed by western-blot (HDL), immunohistochemistry (tissue), and ELISA (plasma). HDL from AAA patients showed elevated expression of peroxiredoxin-6 (PRDX6), HLA class I histocompatibility antigen (HLA-I), retinol-binding protein 4, and paraoxonase/arylesterase 1 (PON1), whereas alpha-2 macroglobulin and C4b-binding protein were decreased. The main pathways associated with HDL alterations in AAA were oxidative stress and immune-inflammatory responses. In AAA tissue, PRDX6 colocalized with neutrophils, vascular smooth muscle cells, and lipid oxidation. Moreover, plasma PRDX6 was higher in AAA (N = 47) than in controls (N = 27), reflecting increased systemic oxidative stress. Finally, a positive correlation was recorded between PRDX6 and AAA diameter. The analysis of the HDL proteome demonstrates that redox imbalance is a major mechanism in AAA, identifying the antioxidant PRDX6 as a novel systemic biomarker of AAA. We thank Simon Bartlett for language and scientific editing. This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2016-80843-R, BIO2012-37926 and BIO2015-67580-P), Fondo de Investigaciones Sanitarias ISCiii-FEDER (PRB2) (IPT13/0001, ProteoRed, Redes RIC RD12/0042/00038 and RD12/0042/0056, Biobancos RD09/0076/00101 and CA12/00371), Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), and FRIAT. The CNIC is supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). Sí
- Subjects :
- Male
Proteomics
0301 basic medicine
Pathology
Proteome
Comorbidity
030204 cardiovascular system & hematology
Bioinformatics
Workflow
Arylesterase
Aortic aneurysm
0302 clinical medicine
NADPH OXIDASE ACTIVITY
RUPTURE
Tandem Mass Spectrometry
OXIDATIVE STRESS
Multidisciplinary
biology
SMOOTH-MUSCLE
Middle Aged
PON1
Macroglobulin
cardiovascular system
Biomarker (medicine)
Female
Lipoproteins, HDL
COMPLEMENT ACTIVATION
medicine.medical_specialty
macromolecular substances
Article
03 medical and health sciences
Lipid oxidation
medicine
Humans
Aged
business.industry
Paraoxonase
Computational Biology
Reproducibility of Results
medicine.disease
030104 developmental biology
ATHEROSCLEROSIS
DISCOVERY
HIGH-DENSITY-LIPOPROTEINS
CELLS
biology.protein
business
Biomarkers
Aortic Aneurysm, Abdominal
Chromatography, Liquid
Peroxiredoxin VI
Subjects
Details
- Language :
- English
- ISSN :
- 20452322
- Database :
- OpenAIRE
- Journal :
- Scientific Reports
- Accession number :
- edsair.doi.dedup.....ee00252fea28c755a333612854a8b423
- Full Text :
- https://doi.org/10.1038/srep38477